PMP22 MLPA Deletion/Duplication Analysis

This assay does not detect inversions, translocations or point mutations. False positive or false negative results may occur for reasons that include insufficient information available about rare genetic variants, pseudogenes, the presence of a sequence variant at a probe ligation site, homologous regions, blood transfusions, bone marrow transplantation, somatic or tissue-specific mosaicism, mislabeled samples or erroneous representation of family relationships. Interpretation of the clinical significance of gene variations is limited by information about the variant that is available at the time of reporting and by the quality and quantity of clinical information provided with the sample. The interpretation of the clinical significance of variants may change.

This test was developed and its performance characteristics determined by Labcorp. It has not been cleared or approved by the Food and Drug Administration.